U.S. Auto Components Stock News

Why Pinterest (PINS) is back on investors’ radar Pinterest (PINS) has drawn fresh attention after recent share price weakness, with the stock showing negative returns over the past year and past 3 months, while revenue and value metrics offer a different snapshot of the business. See our latest analysis for Pinterest. At a share price of US$25.91, Pinterest’s recent moves include a 3 month share price return of 20% decline and a 1 year total shareholder return of 15.13% decline. This points...

Why Silicon Motion Technology (SIMO) Is Back on Investor Radar Silicon Motion Technology (SIMO) has drawn fresh attention after a strong month, with the share price moving while key fundamentals such as revenue, earnings and longer term returns provide important context for anyone tracking the stock. See our latest analysis for Silicon Motion Technology. That recent 33.5% 1 month share price return, on top of a 20.4% year to date share price gain and a 124.0% 1 year total shareholder return,...

Digi International (DGII) has been active on the product front, with SmartSense ONE, Digi Ventus Managed Connectivity Solutions, and new Opengear CM8000 and OM1300 hardware expanding its presence in compliance, 5G connectivity, and network resilience. See our latest analysis for Digi International. Those product launches and Digi’s upcoming first quarter 2026 results sit against a share price of $44.05, with a 90 day share price return of 16.2% and a 1 year total shareholder return of 44.47%...

Werner Enterprises (WERN) has drawn investor attention after a recent stretch of mixed share performance, with gains over the past month and past 3 months contrasting with weaker 1 year and multi year returns. See our latest analysis for Werner Enterprises. With the share price at US$33.14, Werner’s recent momentum appears more short term than long term, with a 90 day share price return of 19.04% contrasting with a 1 year total shareholder return decline of 7.42% and a 3 year total...

Mereo BioPharma Group (NasdaqCM:MREO) has come into focus after releasing mixed Phase 3 results for setrusumab in osteogenesis imperfecta, along with a cash runway update to mid-2027 and progress on its alvelestat and vantictumab programs. See our latest analysis for Mereo BioPharma Group. The mixed Phase 3 readout and cash runway update come after a volatile stretch for the stock, with a 7 day share price return of 29.45% following a 30 day share price return decline of 66.67%, and a 1 year...

Earlier in January 2026, Trump Media & Technology Group Corp. announced four new Truth Social–branded Separately Managed Account investment strategies, offering portfolios built around industrial growth, national security, Christian values, and essential infrastructure themes, seeded with the company’s own capital. This move extends Trump Media’s reach beyond social media into branded financial products, aiming to link its America‑First messaging directly with values‑based investment options...

Why Union Pacific (UNP) Is On Investors’ Radar Today Union Pacific (UNP) has drawn attention after recent share moves, with the stock showing mixed returns over the past week, month, and past 3 months while trading around $229.49 at the latest close. See our latest analysis for Union Pacific. At around $229.49, Union Pacific’s recent share price return has been soft over the past month, although its 1 year total shareholder return of 0.30% and 3 year total shareholder return of 18.00% suggest...

Rigel Pharmaceuticals (RIGL) has drawn fresh attention after launching a Phase 1b/2 trial combining REZLIDHIA with other therapies for acute myeloid leukemia and issuing full year 2026 revenue guidance of US$275 million to US$290 million. See our latest analysis for Rigel Pharmaceuticals. Despite the latest clinical update and 2026 revenue guidance, Rigel Pharmaceuticals’ recent share price performance has cooled, with a 7 day share price return of 8.23% and a 30 day share price return of...

Mueller Water Products triggered by GARP screen Mueller Water Products (MWA) recently passed a Peter Lynch Growth at a Reasonable Price screen, highlighting a mix of earnings growth, PEG based valuation, financial strength, and return on equity that has caught investor attention. See our latest analysis for Mueller Water Products. The GARP trigger comes after a steady run, with a 7 day share price return of 4.24% and a 30 day share price return of 6.39% at a latest close of $26.31, while 1...

Glancy Prongay & Murray LLP has filed a securities class action in the Southern District of Ohio alleging Bath & Body Works misled investors between June 4, 2024 and November 19, 2025, following sharp year-over-year declines in earnings, multiple guidance cuts, and acknowledgment that recent growth initiatives failed to expand its customer base. The lawsuit arrives as Bath & Body Works is both closing more mall locations and refreshing product lines, underscoring the tension between...

If you are wondering whether CAVA Group at around US$72 a share is a bargain or already pricing in a lot of optimism, you are not alone. The stock has returned 1.7% over the last 7 days and 35.7% over the last 30 days, while the year to date return is 19.1% and the 1 year return is a 39.0% decline. Recent coverage has focused on CAVA Group as a newly public fast casual restaurant brand with strong consumer awareness, with attention on how quickly it is expanding its store base and scaling...

Earlier this month, Hankook Tire America Corp. opened the Hankook Tire Clinic Powered by Evernorth at its Clarksville, Tennessee plant, while The Cigna Group also renewed its multiyear sponsorship of Achilles International’s Freedom Team with nearly US$1.00 million committed over three years. Together, these initiatives highlight Cigna’s emphasis on integrated health services and visible community investment in veterans and athletes with disabilities, reinforcing its broader health-focused...

Private Bancorp of America (PBAM) has wrapped up FY 2025 with fourth quarter revenue of US$29.9 million and basic EPS of US$1.75, alongside trailing twelve month revenue of US$119.2 million and EPS of US$7.09. Over recent periods, the company has seen quarterly revenue move from US$26.8 million in Q3 2024 to just over US$30.5 million in Q2 2025, with quarterly EPS ranging from about US$1.64 to US$1.83 over that span. This sets a clear earnings base for investors to work from. With a trailing...

Biogen (BIIB) has come back into focus after the European Commission approved a high dose regimen of SPINRAZA for 5q spinal muscular atrophy, supported by Phase 2/3 DEVOTE trial results and a prior approval in Japan. See our latest analysis for Biogen. These SPINRAZA developments and Biogen's conference presence come after a choppy stretch, with a 7 day share price return of 12.37% decline and a 1 year total shareholder return of 16.98%. This suggests that longer term holders have fared...

If you are wondering whether InterDigital's share price still offers value at current levels, you are not alone. This article walks through what that price might imply about the stock. After a strong 81.7% return over the past year and a very large 3-year gain of about 4x, the stock has recently cooled, with a 0.1% 7-day slip, a 5.0% decline over 30 days, and a 5.4% fall year to date from a last close of US$308.76. Recent attention on InterDigital has been shaped by ongoing interest in...

Kosmos Energy recently reported operational progress, including completing a second Jubilee producer well in Ghana, securing license extensions for the Jubilee and TEN fields to 2040, and confirming that the Greater Tortue Ahmeyim LNG project reached nameplate capacity in December 2025. Together with a planned US$350 million senior secured bond issue to refinance nearer-term debt, these developments reshape Kosmos’ production profile, reserve life, and balance sheet flexibility for years...

If you are wondering whether D.R. Horton at around US$155 a share still offers value, you are not alone. That is exactly what this article will unpack. The stock has had mixed recent returns, with a 0.8% decline over the last 7 days, a 2.6% gain over 30 days, and returns of 7.0% year to date and 6.9% over the last year, on top of a 70.0% return over 3 years and 110.9% over 5 years. Recent coverage around large US homebuilders has focused on how investors are weighing long term housing demand...

J.B. Hunt Transport Services (JBHT) just wrapped up FY 2025 with fourth quarter revenue of US$3.1b and basic EPS of US$1.90, alongside net income of US$181.1m. The company has seen quarterly revenue move from US$3.1b in Q4 2024 to US$3.1b in Q4 2025, while basic EPS shifted from US$1.53 to US$1.90 over the same period. Trailing twelve month EPS stands at US$6.12 on revenue of US$12.0b. With net margin at 5.0% and slightly higher than last year, the focus this season is on how efficiently...

If you are wondering whether Doximity is attractively priced at its current level or if the market is overlooking something in plain sight, this article is for you. The stock is at US$41.26 after a 5.8% decline over the last 7 days, a 5.6% decline over 30 days and a 4.7% decline year to date, while the 3 year return sits at 27.8% and the 1 year return at a 23.2% decline. Recent coverage around Doximity has focused on its role as a digital platform for medical professionals and how that...

Mountain Pacific Bancorp (MPCB) just wrapped up FY 2025 with fourth quarter revenue of about US$10.0 million and net income of US$3.1 million, set against a trailing twelve month total of US$38.7 million in revenue and US$13.1 million in net income. The company has seen revenue move from US$28.7 million to US$38.7 million on a trailing basis, while trailing earnings growth of 67.1% and a net profit margin of 33.9% frame a results season in which profitability and efficiency are front and...

Why this new drug delivery alliance matters for Stevanato Group Datwyler’s new collaboration with LTS Device Technologies and Stevanato Group (STVN) centers on large volume, on body subcutaneous drug delivery, targeting in home use and the growing role of biologic therapies. See our latest analysis for Stevanato Group. Stevanato Group’s latest news on large volume drug delivery comes after a tougher period for the stock, with a 19.19% decline in the 3 month share price return and a 13.33%...

Earlier this month, American Financial Group, Inc. declared a regular cash dividend of US$0.88 per common share, payable on January 27, 2026, to shareholders of record as of January 15, 2026. Wells Fargo has now initiated coverage of American Financial Group with an Overweight rating, highlighting expectations for better 2026 growth supported by the company’s relatively low property exposure and focus on maintaining stable margins and return on equity. We’ll now examine how Wells Fargo’s...

Niagen Bioscience (NAGE) has drawn fresh attention after announcing a partnership with Truemed that lets qualified customers buy Tru Niagen using Health Savings Account and Flexible Spending Account funds on its direct website. See our latest analysis for Niagen Bioscience. That HSA and FSA payment update arrives after a period of softer momentum, with a 90 day share price return of a 15.55% decline and a year to date share price return of a 0.96% decline, even as the three year total...

If you are wondering whether SouthState Bank's share price reflects its true worth, you are not alone. This article walks through what the current market price might be implying about value. The stock last closed at US$98.43, with returns of 0.8% over the past week, 0.8% over the last month, 4.5% year to date and 1.2% over the past year, while the 3 year and 5 year returns sit at 37.1% and 40.1% respectively. Recent moves in U.S. regional bank shares have kept investor attention on balance...